Long QT Syndrome
A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
Subtype terms (3)
More specific conditions that are subtypes of Long QT Syndrome in the MeSH hierarchy.
- Andersen Syndrome
3 drugs (2 approved, 1 experimental)
- Jervell-Lange Nielsen Syndrome
3 drugs approved
- Romano-Ward Syndrome
2 drugs (1 approved, 1 experimental)
Drugs by status
Phase 4 trials (4)
Phase 2 trials (5)
Phase 1 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (2)